Herpes simplex virus thymidine kinase/ganciclovir-mediated killing of tumor cells induces tumor-specific cytotoxic T cells in mice

Cancer Gene Therapy

Volumn 4, Issue 2, 1997, Pages 91-96

  Yamamoto, Shiro ^a   Suzuki, Satoru ^a   Hoshino, Arichika ^a   Akimoto, Masao ^a   Shimada, Takashi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Antitumor immunity; Ganciclovir; Gene therapy; Herpes simplex virus; MHC class I; Thymidine kinase

Indexed keywords

ANTIMETABOLITE; GANCICLOVIR; HLA ANTIGEN CLASS 1; THYMIDINE KINASE;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CARCINOMA; CELL CULTURE; CELL TRANSPLANTATION; CYTOTOXIC T LYMPHOCYTE; DRUG EFFECT; ENZYMOLOGY; EXPERIMENTAL NEOPLASM; FEMALE; GENE THERAPY; GENETICS; HERPES SIMPLEX VIRUS; IMMUNOLOGY; KIDNEY TUMOR; METABOLISM; METHODOLOGY; MOUSE; NEOPLASM; PATHOLOGY;

ANIMALS; ANTIMETABOLITES; CARCINOMA; CELL TRANSPLANTATION; FEMALE; GANCICLOVIR; GENE THERAPY; HISTOCOMPATIBILITY ANTIGENS CLASS I; KIDNEY NEOPLASMS; MICE; MICE, INBRED BALB C; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; SIMPLEXVIRUS; T-LYMPHOCYTES, CYTOTOXIC; THYMIDINE KINASE; TUMOR CELLS, CULTURED;

EID: 0031085078     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Culver KW, Ram Z, Walbridge S, Ishii H, Oldfield EH, Blaese RM. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science. 1992;256:1550-1552.
2. Caruso M, Panis Y, Gagandeep S, Houssin D, Salzmann JL, Klatzmann D. Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. Proc Natl Acad Sci USA. 1993;90:7024-7028.
3. Oldfield EH, Ram Z, Culver KW, Blaese RM, DeVroom HL, Anderson WF. Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Hum Gene Ther. 1993;4:39-69.
4. Plautz G, Nabel EG, Nabel GJ. Selective elimination of recombinant genes in vivo with a suicide retroviral vector. New Biologist. 1991;3:709-715.
5. Cheng YC, Grill SP, Dutschman GE, Nakayama K, Bastow KF. Metabolism of 9-(1,3-dihydroxy-2-propoxymethyl) guanine, a new anti-herpes virus compound, in herpes simplex virus-infected cells. J Biol Chem. 1983;258:12460-4.
6. Kun LE, Gajjar A, Muhlbauer M, Heideman RL, Sanford R, Brenner M, Walter A, Langston J, Jenkins J, Facchini S. Stereotactic injection of herpes simplex thymidine kinase vector producer cells (pa317-g1tk1svna.7) and intravenous ganciclovir for the treatment of progressive or recurrent primary supratentorial pediatric malignant brain tumors. Hum Gene Ther. 1995;6:1231-1255.
7. Freeman SM, Abboud CN, Whartenby KA, Packman CH, Koeplin DS, Moolten FL, Abraham GN. The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res. 1993;53:5274-83.
8. Vile RG, Nelson JA, Castleden S, Chong H, Hart IR. Systemic gene therapy of murine melanoma using tissue specific expression of the hsvtk gene involves an immune component. Cancer Res. 1994;54:6228-6234.
9. Bi WL, Parysek LM, Warnick R, Stambrook PJ. In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy. Hum Gene Ther. 1993;4:725-731.
10. Bi WL, Parysek LM, Warnick R, Stambrook PJ. In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with hsv tk retroviral gene therapy. Hum Gene Ther. 1993;4:725-731.
11. Fick J, Barker FG, Dazin P, Westphale EM, Beyer EC, Israel MA. The extent of heterocellular communication mediated by gap junctions is predictive of bystander tumor cytotoxicity in vitro. Proc Natl Acad Sci USA. 1995;92: 11071-11075.
12. Barba D, Hardin J, Sadelain M, Gage FH. Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors. Proc Natl Acad Sci USA. 1994;91:4348-4352.
13. Murphy GP. A murine renal cell carcinoma. J Natl Cancer Inst. 1973;50:1013.
14. Wilkie NM, Clements JB, Boll W, Mantei N, Lonsdale D, Weissmann C. Hybrid plasmids containing an active thymidine kinase gene of herpes simplex virus 1. Nucleic Acids Res. 1979;7:859-877.
15. Miller AD, Buttimore C. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol Cell Biol. 1986;6:2895-2902.
16. Itsuki Y, Suzuki S. Expression of interleukin-4 in colon 26 cells induces both eosinophil mediated local tumor killing and T-cell mediated systemic immunity in vivo. J Nippon Med Sch. 1996;63:275-285.
17. Tepper RI, Coffman RL, Leder P. Murine interleukin-4 displays potent anti-tumor activity in vivo. Cell. 1989;57: 503-512.
18. Rollinghohh M, Warner NL. Specificity of in vivo tumor rejection assessed by mixing immune spleen cells with target and unrelated tumor cells. Proc Soc Exp Biol Med. 1973:144:813-818.
19. Zhang WW, Fang X, Mazur W, French BA, Georges RN, Roth JA. High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus. Cancer Gene Ther. 1994;1:5-13.
20. Friedmann T. Gene therapy of cancer through restoration of tumor-suppressor functions? Cancer. 1992;70:1810-7.
21. Mercola D, Cohen JS. Antisense approaches to cancer gene therapy. Cancer Gene Ther. 1995;2:47-59.
22. Fearon ER, Pardoll DM, Itaya T, Golumbek P, Levitsky HI, Simons JW, Karasuyama H, Vogelstein B, Frost P. Interleukin-2 production by tumor cells bypasses t helper function in the generation of an antitumor response. Cell. 1990;60:397-403.
23. Golumbek PT, Lazenby AJ, Levitsky HI, Jaffee LM, Karasuyama H, Baker M, Pardoll DM. Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4. Science. 1991;254:713-716.
24. Dranoff G, Jaffee E, Lazenby A, Golumbek P, Levitsky H, Brose K, Jackson V, Hamada H, Pardoll D, Mulligan RC. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA. 1993;90: 3539-3543.
25. Yang G, Hellstrom KE, Hellstrom I, Chen L. Antitumor immunity elicited by tumor cells transfected with B7-2, a second ligand for CD28/CTLA-4 costimulatory molecules. J Immunol. 1995;154:2794-2800.
26. Berns AJ, Clift S, Cohen LK, Donehower RC, Dranoff G, Hauda KM, Lazenby AJ, Levitsky HI, Marshall FF, et al. Phase I study of non-replicating autologous tumor cell injections using cells prepared with or without GM-CSF gene transduction in patients with metastatic renal cell carcinoma. Hum Gene Ther. 1995;6:347-368.
27. Sobol RE, Royston I, Fakhrai H, Shawler DL, Carson C, Dorigo O, Gold DP, Koziol J, Mercola D, et al. Injection of colon carcinoma patients with autologous irradiated tumor cells and fibroblasts genetically modified to secrete interleukin-2 (IL-2): a phase I study. Hum Gene Ther. 1995;6:195-204.
28. Ram Z, Culver KW, Walbridge S, Blaese RM, Oldfield EH. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res. 1993;53:83-8.
29. Hock H, Dorsch M, Kunzendorf U, Uberla K, Qin Z, Diamantstein T, Blankenstein T. Vaccinations with tumor cells genetically engineered to produce different cytokines: effectivity not superior to a classical adjuvant. Cancer Res. 1993;53:714-716.
30. Boviatsis EJ, Park JS, Sena-Esteves M, Kramm CM, Chase M, Efird JT, Wei MX, Breakefield XO, Chiocca EA. Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase gene. Cancer Res. 1994;54:5745-5751.
31. Sugiura K, Stock CC. Studies in a tumor spectrum. III. The effect of phosphoramides on the growth of a variety of mouse and rat tumors. Cancer Res. 1955;15:38-51.
32. Abdel-Wahab ZA, Osanto S, Darrow TL, Barber JR, Vervaert CE, McCallister TJ, Seigler HF. Transduction of human melanoma cells with the gamma interferon gene enhances cellular immunity. Cancer Gene Ther. 1994;1: 171-179.
33. Ogasawara M, Rosenberg SA. Enhanced expression of HLA molecules and stimulation of autologous human tumor infiltrating lymphocytes following transduction of melanoma cells with gamma-interferon genes. Cancer Res. 1993;53:3561-3568.
34. Freeman SM, Ramesh R, Shastri M, Munshi A, Jensen AK, Marrogi AJ. The role of cytokines in mediating the bystander effect using HSV-TK xenogeneic cells. Cancer Lett. 1995;92:167-174.
35. Hogquist KA, Nett MA, Unanue ER, Chaplin DD. Interleukin 1 is processed and released during apoptosis. Proc Natl Acad Sci USA. 1991;88:8485-8489.